A series of studies have examined the action of VDR agonists on putative breast cancer stem or progenitor cells identified by some markers (CD44hi/CD24low and/or ADH1+) that can grow as floating, nonadherent spheres (mammospheres). The gene discussed is VDR; the disease is breast carcinoma.